ADA and cancer: In contrast, we observed that cordycepin significantly suppressed EBV gene expression and lytic reactivation [15]; and secondly, adenosine deaminase (ADA) converts cordycepin to 3′-deoxyinosine which does not exhibit anti-cancer effects as much as the original cordycepin [16,17,18].